Delivery Order SPE2DB24D6038-SPE2DB25FELHN

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,432.75 firm fixed-price delivery order is for the supply of 4565626834 - Procainamide 1 Gram/10 ML Vial 10ML, a critical pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,679.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the procurement of Procainamide, a pharmaceutical product used for medical treatment. The contract has a firm fixed price pricing type and an ultimate completion date of December 17, 2024. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,377.46 firm-fixed-price delivery order is for the supply of 4557691980 – Procainamide 1 Gram/10 ML Vial 10ML. The contract has an ultimate completion date of July 1, 2022 and was awarded on June 30, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,140.57, is for the supply of 4561655760 - Procainamide 1 gram/10 ml vial, 10 ml. The contract has an ultimate completion date of August 1, 2023 and was awarded on July 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,817.68 firm fixed-price delivery order is for the supply of PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,717.78 delivery order contract is for the supply of 4566997370 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a firm fixed price pricing type and an ultimate completion date of January 22, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,232.45 firm fixed price delivery order is for the supply of 4566137396 - PROCAINAMIDE 1,000 MG/10 ML VL 10ML, with a period of performance through October 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,450.90 firm fixed-price delivery order is for the procurement of 4566926536 - PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Procainamide 1 gram/10 ml vials. The $1,917.52 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support...
  • SPE2DB24D6038
    Indefinite Delivery Contract
  • SPE2DB24D6038-SPE2DB25FELHN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,887.15 firm fixed-price delivery order is for procainamide 1 gram/10 mL vials, with a completion date of November 1, 2024. This contract is not designated as a set-aside.

Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/30/25, 9:22 AM